NCT00464880View on ClinicalTrials.gov

Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

November 30, 2007

Conditions
Diabetes Type 2
Interventions
DRUG

Aliskiren

Trial Locations (1)

2820

Novartis, Gentofte Municipality

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00464880 - Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy | Biotech Hunter | Biotech Hunter